Active Pharmaceutical Ingredients Global Market - Forecast to 2022

  • ID: 3727175
  • Report
  • Region: Global
  • 369 Pages
  • IQ4I Research & Consultancy Pvt. Ltd
1 of 5
The Global Active Pharmaceutical Ingredient Market Is Expected to Reach Approximately $175 Billion by 2020

FEATURED COMPANIES

  • Aarti Drugs Ltd
  • Bayer Pharma Chemicals
  • Ctx Lifesciences
  • Lilly Pharmaceuticals
  • Novartis Ag
  • Salix Pharmaceuticals
  • MORE
Active pharmaceutical ingredient is any substance or mixture of substances used in a finished pharmaceutical product with pharmacological activity used for diagnosis, cure, mitigation, treatment and prevention of diseases.

Very few numbers of finished pharmaceutical product manufacturers has their own API manufacturing unit and nobody can make all required APIs in-house. It is basically not easy for API manufacturers in developing countries to ensure a product with quality at a reasonable price. API manufacturing involves conversion of raw materials into API and mixing API and excipients for final formulations. These formulations in the form of tablets, capsules or solutions are packaged and then marketed.

Patent expiration of major drugs that increased generic drug sales, government initiatives, increasing aged population and regional penetration, local manufacturer expansion and high uptake of biologics are some of the factors that are driving the market growth. Whereas financial crisis, stringent regulatory policies, less investment in pharmaceutical industry and fragmented market are the factors that are hindering API market growth.

The global API market is segmented based on synthesis, customer base, business type and therapeutic applications. Depending on synthesis the market is classified into synthetic chemical API, biotech API and HPAPI (Highly Potent Active Pharmaceutical Ingredient). Biotech API is further segmented into mammalian cell culture, monoclonal antibodies, recombinant proteins, vaccines, insulin analog, growth hormones and interferons.

Mammalian cell culture accounted for the largest share in 2013, while monoclonal antibody segment is the fastest growing segment by 2020. Despite low production yields, high manufacturing cost and highly unstable cell culturing method mammalian culture is the largest due to post-translational mechanism present in living cells. Monoclonal antibodies are growing at a faster pace due to demand for biotech APIs and increasing venture capital investments that drives the market.

By-customer base the API market is segmented into synthetic chemicals API, biotech API and HPAPI. Synthetic chemical API is further classified into branded/innovative and generic/non-branded API. Branded API accounted for the largest share whereas, generic is the fastest growing segment. Biotech API is further divided into biologics and biosimilars where biologics accounted for the largest share.

Depending on business type the API market is segmented into captive and merchant. Captive market accounted for the largest revenue in 2013. Based on the therapeutic applications the global API market is categorized into eleven crucial application areas such as anti-infectives, oncology, cardiovascular and hematopoietic system, central nervous system, gastrointestinal disorder, respiratory system, hormonal-related disorder, metabolic disorder, genito-urinary disorder, musculo-skeletal disorder and others.

Anti-infectives segment dominated the application market with a largest in 2013 whereas oncology segment is the fastest growing segment with a CAGR of approximately 8% by 2020. Patent expiration of major drugs, increased incidence of various cancer diseases and aged population, high government investments for cancer research and healthcare awareness are the factors that drives the market whereas stringent regulations, failure of crucial drugs in last stage of clinical trial, and economical crisis are the factors that hampers the market growth.

Geographically API market is segmented into North America, Asia-Pacific, Europe and Rest of the world regions. North America dominated the global API market during the forecast period. Asia Pacific region is the fastest growing with a CAGR of more than 7.5% by 2020 due to patent expirations of drugs, low operation costs, services of Contract Manufacturing Organizations (CMO) and high investments in medical research. Moreover the high cost of skilled labor and energy are the major factors that forced European market to shift their base to countries such as India and China.

Major players in the API market include Teva Active Pharmaceutical Industries Limited (Israel), Ranbaxy Laboratories (India), Dr. Reddy's Lab (India), Boehringer Ingelheim GmbH (Germany), Lonza group (Switzerland), Lupin (India), Novartis (Switzerland), Aurobindo pharma (India), and Albemarle Corporation (U.S.).

The report provides an in depth market analysis of the above mentioned segments across the following regions:

- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Aarti Drugs Ltd
  • Bayer Pharma Chemicals
  • Ctx Lifesciences
  • Lilly Pharmaceuticals
  • Novartis Ag
  • Salix Pharmaceuticals
  • MORE
1 Executive Summary
2 Introduction
2.1 Key Take Aways
2.2 Report Description
2.3 Markets Covered
2.4 Stakeholders
2.5 Research Methodology
2.5.1 Market Size Estimation
2.5.2 Market Crack Down & Data Triangulation
2.5.3 Secondary Sources
2.5.4 Key Data Points From Secondary Resources
2.5.5 Primary Sources
2.5.6 Key Data Point From Primary Sources
2.5.7 Assumptions

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers And Opportunities
3.3.1.1 Patent Expiration Of Major Drugs Enhanced Generics Sales
3.3.1.2 Government Initiation On Biomedical Research
3.3.1.3 Increasing Scope Of HpAPI Market
3.3.1.4 High Uptake Of Biologics Across Diverse Therapeutic Areas
3.3.1.5 Increasing Regional Penetration And Aged Population
3.3.1.6 Increasing Mergers And Acquisitions
3.3.1.7 Expansion Of Local API Manufacturers
3.3.1.8 Global API Outsourcing
3.3.2 Restraints And Threats
3.3.2.1 Delay In Approval Of New Drugs
3.3.2.2 Low Investment In API Market Due To Economic Downturn
3.3.2.3 High Production Cost For Manufacturing APIs
3.3.2.4 Fierce Competition Between API Players
3.3.2.5 Stringent Regulatory Policies
3.3.2.6 Global Financial Crisis
3.3.2.7 High Market Fragmentation And Genericization Of Branded Drugs
3.3.3 Burning Issues
3.3.3.1 Contamination In Formulation And Bulk Drugs
3.3.3.2 Inflate Drug Prices
3.3.4 Winning Imperative
3.3.4.1 Low Cost Labor Market
3.3.5 Market Trends
3.4 Regulatory Affairs
3.4.1 U.S.
3.4.2 Europe
3.4.3 Asia Pacific
3.4.4 Rest Of The World
3.5 Porter’S Five Force Analysis
3.5.1 Threat Of New Entrants
3.5.2 Threat Of Substitutes
3.5.3 Rivalry Among Existing Competitors
3.5.4 Bargaining Power Of Buyers
3.5.5 Bargaining Power Of Suppliers
3.6 Supply Chain Analysis
3.7 Capacity Utilization
3.8 API Manufacturing Units
3.9 Selected Top Selling API
3.10 Market Share Analysis

4 Global API Market Overview
4.1 By Synthesis
4.1.1 Synthetic Chemicals API
4.1.2 Biotech API
4.1.2.1 Introduction
4.1.2.2 Monoclonal Antibodies
4.1.2.3 Recombinant Proteins
4.1.2.4 Vaccines
4.1.2.5 Others
4.1.3 HpAPI
4.2 By Customer Base
4.2.1 Synthetic Chemicals
4.2.1.1 Branded/Innovative Synthetic Chemicals
4.2.1.2 Generic/Non- Branded Synthetic Chemicals
4.2.2 Biotech API
4.2.2.1 Biologics
4.2.2.2 Biosimilars
4.2.3 HpAPI
4.3 By Business Type
4.3.1 Captive
4.3.2 Merchant

5 Global API Market, By Therapeutic Application
5.1 Introduction
5.2 Anti-Infectives
5.3 Oncology
5.4 Cardiovascular And Hematopoietic System
5.5 Central Nervous System
5.6 Respiratory System
5.7 Gastrointestinal
5.8 Hormone-Related Disorders
5.9 Metabolic Disorders
5.9.1 Diabetes
5.9.2 Obesity
5.10 Genitourinary Disorders
5.11 Musculoskeletal Disorders
5.12 Others
5.12.1 Anesthesia
5.12.2 Eye
5.12.3 Ent (Ear Nose Throat) Disorders

6 Regional Market Analysis
6.1 Introduction
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Rest Of The World

7 Company Developments
7.1 Introduction
7.2 Approval
7.3 Agreements, Partnerships, Collaborations & Joint Ventures
7.4 New Product Launch
7.5 Mergers And Acquisitions
7.6 Other Developments

8 Major Player Profiles
8.1 Albemarle Corporation
8.1.1 Overview
8.1.2 Financials
8.1.3 Product Portfolio
8.1.4 Key Developments
8.1.5 Business Strategy
8.1.6 Swot Analysis
8.2 Aurobindo Pharma Limited
8.2.1 Overview
8.2.2 Financials
8.2.3 Product Portfolio
8.2.4 Key Developments
8.2.5 Business Strategy
8.2.6 Swot Analysis
8.3 Boehringer Ingelheim Gmbh
8.3.1 Overview
8.3.2 Financials
8.3.3 Product Portfolio
8.3.4 Key Developments
8.3.5 Business Strategy
8.3.6 Swot Analysis
8.4 Dr. Reddy’S Laboratories Limited
8.4.1 Overview
8.4.2 Financials
8.4.3 Product Portfolio
8.4.4 Key Developments
8.4.5 Business Strategy
8.4.6 Swot Analysis
8.5 Fresenius Kabi
8.5.1 Overview
8.5.2 Financials
8.5.3 Product Portfolio
8.5.4 Key Developments
8.5.5 Business Strategy
8.5.6 Swot Analysis
8.6 Lonza Group Ltd
8.6.1 Overview
8.6.2 Financials
8.6.3 Product Portfolio
8.6.4 Key Developments
8.6.5 Business Strategy
8.6.6 Swot Analysis
8.7 Lupin Limited
8.7.1 Overview
8.7.2 Financials
8.7.3 Product Portfolio
8.7.4 Key Developments
8.7.5 Business Strategy
8.7.6 Swot Analysis
8.8 Novartis International Ag
8.8.1 Overview
8.8.2 Financials
8.8.3 Product Portfolio
8.8.4 Key Developments
8.8.5 Business Strategy
8.8.6 Swot Analysis
8.9 Sun Pharmaceuticals Industries Ltd
8.9.1 Overview
8.9.2 Financials
8.9.3 Product Portfolio
8.9.4 Key Developments
8.9.5 Business Strategy
8.9.6 Swot Analysis
8.10 Teva Active Pharmaceutical Ingredients
8.10.1 Overview
8.10.2 Financials
8.10.3 Product Portfolio
8.10.4 Key Developments
8.10.5 Business Strategy
8.10.6 Swot Analysis

List Of Tables
Table 1 Active Parmaceutical Ingredient Global Market Revenue, By Region, (2014-2022) ($Bn)
Table 2 Global API Market Revenue, By Synthesis, (2014-2022) ($Bn)
Table 3 Synthetic Chemicals API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 4 Biotech API Global Market Revenue, By Type (2014-2022) ($Bn)
Table 5 Biotech API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 6 Monoclonal Antibodies Biotech API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 7 Recombinant Proteins Biotech API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 8 Vaccines Biotech API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 9 Others Biotech API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 10 HpAPI Global Market Revenue, By Region (2014-2022) ($Bn)
Table 11 Synthetic Chemicals API Global Market Revenue, By Customer Base (2014-2022) ($Bn)
Table 12 Branded/Innovative Synthetic Chemicals API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 13 Generic/Non-Branded Synthetic Chemicals API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 14 Biotech API Global Market Revenue, By Customer Base (2014-2022) ($Bn)
Table 15 Biologics Biotech API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 16 Biosimilars Biotech API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 17 HpAPI Global Market Revenue, By Region (2014-2022) ($Bn)
Table 18 API Global Market Revenue, By Business Type (2014-2022) ($Bn)
Table 19 Captive API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 20 Merchant API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 21 API Global Market Revenue, By Therapeutic Applications (2014-2022) ($Bn)
Table 22 Synthetic Chemicals Global API Market Revenue, By Therapeutic Applications, (2014-2022) ($Mn)
Table 23 Biotech API Global Market Revenue, By Therapeutic Applications, (2014-2022) ($Mn)
Table 24 HpAPI Global Market Revenue, By Therapeutic Applications, (2014-2022) ($Mn)
Table 25 Anti-Infectives API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 26 Synthetic Anti-Infectives API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 27 Biotech Anti-Infectives API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 28 HpAPI Anti-Infectives API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 29 Oncology API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 30 Synthetic Oncology API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 31 Biotech Oncology API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 32 HpAPI OncologyAPI Global Market Revenue, By Region (2014-2022) ($Bn)
Table 33 Cardiovascular And Hematopoietic System API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 34 Synthetic Cardiovascular And Hematopoietic System API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 35 Biotech Cardiovascular And Hematopoietic System API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 36 HpAPI Cardiovascular And Hematopoietic System API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 37 Central Nervous System API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 38 Synthetic Central Nervous System API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 39 Biotech Central Nervous System API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 40 HpAPI Central Nervous System API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 41 Respiratory System API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 42 Synthetic Respiratory System API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 43 Biotech Respiratory System API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 44 HpAPI Respiratory System API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 45 Gastrointestinal API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 46 Synthetic Gastrointestinal API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 47 Biotech Gastrointestinal API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 48 HpAPI Gastrointestinal API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 49 Hormonal Related Disorders API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 50 Synthetic Hormonal Related API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 51 Biotech Hormonal Related API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 52 HpAPI Hormonal Related API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 53 Metabolic Disorders API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 54 Synthetic Metabolic Disorders API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 55 Biotech Metabolic Disorders API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 56 HpAPI Metabolic Disorders API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 57 Genito-Urinary Disorders API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 58 Synthetic Genito-Urinary API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 59 Biotech Genito-Urinary API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 60 HpAPI Genito-Urinary API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 61 Musculo-Skeletal Disorders API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 62 Synthetic Musculo-Skeletal API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 63 Biotech Musculo-Skeletal API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 64 HpAPI Musculo-Skeletal API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 65 Others API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 66 Synthetic Others API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 67 Biotech Others API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 68 HpAPI Others API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 69 API Global Market Revenue, By Region (2014-2022) ($Bn)
Table 70 North American API Market Revenue, By Synthesis, (2014-2022) ($Bn)
Table 71 North American Biotech API Market Revenue, By Type (2014-2022) ($Bn)
Table 72 North American Synthetic Chemicals API Global Market Revenue, By Customer Base (2014-2022) ($Bn)
Table 73 North American Biotech API Global Market Revenue, By Customer Base (2014-2022) ($Bn)
Table 74 North American API Market Revenue, By Business Type (2014-2022) ($Bn)
Table 75 North American API Market Revenue, By Therapeutic Applications (2014-2022) ($Bn)
Table 76 North American Synthetic Chemicals API Market Revenue, By Therapeutic Applications (2014-2022) ($Bn)
Table 77 North American Biotech API Market Revenue, By Therapeutic Applications (2014-2022) ($Bn)
Table 78 North American HpAPI Market Revenue, By Therapeutic Applications (2014-2022) ($Bn)
Table 79 European API Market Revenue, By Synthesis (2014-2022) ($Bn)
Table 80 European Biotech API Market Revenue, By Type (2014-2022) ($Bn)
Table 81 European Synthetic Chemicals API Global Market Revenue, By Customer Base (2014-2022) ($Bn)
Table 82 European Biotech API Global Market Revenue, By Customer Base (2014-2022) ($Bn)
Table 83 European API Market Revenue, By Business Type (2014-2022) ($Bn)
Table 84 European API Market Revenue, By Therapeutic Applications (2014-2022) ($Bn)
Table 85 European Synthetic Chemicals API Market Revenue, By Therapeutic Applications (2014-2022) ($Bn)
Table 86 European Biotech API Market Revenue, By Therapeutic Applications, (2014-2022) ($Bn)
Table 87 European HpAPI Market Revenue, By Therapeutic Applications (2014-2022) ($Bn)
Table 88 Asia-Pacific API Market Revenue, By Synthesis (2014-2022) ($Bn)
Table 89 Asia-Pacific Biotech API Market Revenue, By Type (2014-2022) ($Bn)
Table 90 Asia-Pacific Synthetic Chemicals API Global Market Revenue, By Customer Base (2014-2022) ($Bn)
Table 91 Asia-Pacific Biotech API Global Market Revenue, By Customer Base (2014-2022) ($Bn)
Table 92 Asia-Pacific API Market Revenue, By Business Type (2014-2022) ($Bn)
Table 93 Asia-Pacific API Market Revenue, By Therapeutic Applications (2014-2022) ($Bn)
Table 94 Asia-Pacific Synthetic Chemicals API Market Revenue, By Therapeutic Applications (2014-2022) ($Bn)
Table 95 Asia-Pacific Biotech API Market Revenue, By Therapeutic Applications (2014-2022) ($Bn)
Table 96 Asia-Pacific HpAPI Market Revenue, By Therapeutic Applications (2014-2022) ($Bn)
Table 97 Row API Market Revenue, By Synthesis (2015-2022) ($Bn)
Table 98 Row Biotech API Market Revenue, By Type (2014-2022) ($Bn)
Table 99 Row Synthetic Chemicals API Global Market Revenue, By Customer Base (2014-2022) ($Bn)
Table 100 Row Biotech API Global Market Revenue, By Customer Base (2014-2022) ($Bn)
Table 101 Row API Market Revenue, By Business Type (2014-2022) ($Bn)
Table 102 Row API Market Revenue, By Therapeutic Applications (2014-2022) ($Bn)
Table 103 Row Synthetic Chemicals API Market Revenue, By Therapeutic Applications (2014-2022) ($Bn)
Table 104 Row Biotech API Market Revenue, By Therapeutic Applications (2014-2022) ($Bn)
Table 105 Row HpAPI Market Revenue, By Therapeutic Applications (2014-2022) ($Bn)
Table 106 Approvals (2015-2016)
Table 107 Agreements, Partnerships, Collaborations & Joint Ventures (2015-2016)
Table 108 New Product Launches (2015-2016)
Table 109 Mergers And Acquisitions (2014-2016)
Table 110 Other Developments (2013)
Table 111 Albemarle Corporation : Total Revenue And R&D Expenses, (2013-2015) ($Bn)
Table 112 Albemarle Corporation.: Total Revenue, By Segments (2013-2015) ($Bn)
Table 113 Albemarle Corporation.: Total Revenue, By Geography (2013-2015) ($Bn)
Table 114 Aurobindo Pharma Limited: Total Revenue And R&D Expenses (2013-15) ($Bn)
Table 115 Aurobindo Pharma Limited: Total Revenue, By Segment (2013-15) ($Bn)
Table 116 Aurobindo Pharma Limited: Total Revenue, By Geography (2013-15) ($Bn)
Table 117 Boehringer Ingelheim Gmbh: Total Revenue And R&D Expenses (2013-2015) ($Bn)
Table 118 Boehringer Ingelheim Gmbh Total Revenue, By Segments (2013-2015) ($Bn)
Table 119 Boehringer Ingelheim Gmbh Total Revenue, By Geography (2013-2015) ($Bn)
Table 120 Dr. Reddy’S Laboratories Limited: Total Revenue And R&D Expenses (2013-2015) ($Bn)
Table 121 Dr. Reddy’S Laboratories Limited: Total Revenue, By Segment (2013-2015) ($Bn)
Table 122 Dr. Reddy’S Laboratories Limited: Total Revenue, By Geography (2013-2015) ($Bn)
Table 123 Fresenius: Total Revenue And R&D Expenses (2013-2015) ($Bn)
Table 124 Fresenius: Total Revenue, By Business Segments (2013-2015) ($Bn)
Table 125 Fresenius: Total Revenue, By Geography (2013-2015) ($Bn)
Table 126 Lonza Group Ltd: Total Revenue And R&D Expenses (2013-2015) ($Bn)
Table 127 Lonza Group Ltd: Total Revenue, By Segments (2013-2015) ($Bn)
Table 128 Lonza Group Ltd: Total Revenue, By Geography (2013-2015) ($Bn)
Table 129 Lupin Limited: Total Revenue And R&D Expenses (2013-2015) ($Bn)
Table 130 Lupin Limited: Total Revenue, By Segment (2013-2015) ($Bn)
Table 131 Lupin Limited: Total Revenue, By API Segment (2013-2015) ($Bn)
Table 132 Lupin Limited: Total Revenue, By Geography (2013-2015) ($Bn)
Table 133 Novartis International Ag.: Total Revenue And R&D Expenses (2013-2015) ($Bn)
Table 134 Novartis International Ag.: Total Revenue, By Segments (2013-2014) ($Bn)
Table 135 Novartis International Ag.: Total Revenue, By Pharmaceutical Segment (2013-2015) ($Mn)
Table 136 Novartis International Ag.: Total Revenue, By Geography (2013-2015) ($Bn)
Table 137 Sun Pharmaceuticals Industries Ltd: Total Revenue And R&D Expenses (2013-2015) ($Bn)
Table 138 Sun Pharmaceuticals Industries Ltd: Total Revenue, By Segments (2013-2015) ($Bn)
Table 139 Teva Pharmaceutical Industries Limited: Total Revenue And R&D Expenses (2013-2015) ($Bn)
Table 140 Teva Pharmaceutical Industries Limited: Total Revenue, By Segments (2013-2015) ($Bn)
Table 141 Teva Pharmaceutical Industries Limited: Total Revenue, By Geography (2013-2015) ($Mn)

List Of Figures
Figure 1 Global API Market Revenue, By Region (2015)
Figure 2 Research Methodology:Active Pharmaceutical Ingredient Market
Figure 3 Active Pharmaceutical Ingredient Market: Top-Down And Bottom-Up Approach
Figure 4 Active Pharmaceutical Ingredient Market: Forecasting Model
Figure 5 API Market: Market Crackdown & Data Triangulation
Figure 6 Global API Market: Market Segmentation
Figure 7 Market Dynamics
Figure 8 API Market: Porter’S Analysis
Figure 9 API Market: Supply Chain Analysis
Figure 10 Global API Capacity Utilization Rate, 2015
Figure 11 Global API Manufacturing Landscape
Figure 12 Global API Market Share Analysis, 2015 (%)
Figure 13 Global API Market Revenue, By Synthesis Type (2015 V’S 2022) ($Bn)
Figure 14 Global Biotech API Market Share, By Synthesis Type (2015 V’S 2022)
Figure 15 Global Synthetic Chemicals API Market Share, By Customer Base (2015 V’S 2022)
Figure 16 Global Biotech API Market Share, By Customer Base (2015 V’S 2022)
Figure 17 Global API Market Revenue, By Business Type (2014 €“ 2022)
Figure 18 Global API Market Share, By Therapeutic Applications (2015) (%)
Figure 19 Global API Market Scenario, By Region (2014 - 2022) ($Bn)
Figure 20 North American API Market Revenue, By Synthesis, Business Type And Application (2015 V’S 2022) ($Bn)
Figure 21 European API Market Revenue, By Synthesis, Business Type And Application (2015 V’S 2022) ($Bn)
Figure 22 Asia Pacific API Market Revenue, By Synthesis, Business Type And Application (2015 V’S 2022) ($Bn)
Figure 23 Row API Market Revenue, By Synthesis, Business Type And Application (2015 V’S 2022) ($Bn)
Figure 24 Key Growth Strategies, (2013-2016)
Figure 25 Swot: Albemarle Corporation
Figure 26 Swot: Aurobindo Pharma Limited
Figure 27 Swot: Boehringer Ingelheim Gmbh
Figure 28 Swot: Dr. Reddy’S Laboratories Limited
Figure 29 Swot: Fresenius Kabi
Figure 30 Swot: Lonza Group Ltd
Figure 31 Swot: Lupin Limited
Figure 32 Swot: Novartis International Ag
Figure 33 Swot: Sun Pharmaceuticals Industries Ltd
Figure 34 Swot: Teva Active Pharmaceutical Ingredient
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Aarti Drugs Ltd
- Abbvie
- Actavis Pharmaceuticals
- Ajantha Pharma
- Akorn
- Albany Molecular Research Inc (Amri)
- Alembic Ltd
- Amneal Pharmaceuticals Llc
- Apotex Fermentation Inc
- Aqvida Gmbh
- Arena Pharmaceuticals
- Arevipharma Gmbh
- Ariston Pharma Novatech Pvt Ltd
- Aurobindo Pharma
- Basf
- Bayer Pharma Chemicals
- Biocon Ltd
- Biodel Corporation
- Biosortia Pharmaceuticals
- Boehringer Ingelheim Gmbh
- Bristol-Myers Squibb
- Cadila Pharmaceuticals Limited
- Cambrex Corporation
- Catalent
- Century Pharmaceuticals Ltd
- Cepia Sanofi
- Cipla Limited
- Ckd Bio
- Corden Pharma
- Ctx Lifesciences
- Daiichi Sankyo Chemical Pharma Co Ltd
- Dishman Pharmaceuticals
- Dr.Reddy’S Laboratories
- Eirgen Pharma
- Emcure Pharmaceuticals Ltd
- Fermion
- Florentis Pharmaceuticals Pvt Ltd
- Global Merchants
- Heni Chemical Industries
- Indena
- Janssen Pharmaceutica Nv
- Kosher Pharmaceuticals
- Krka Pharmaceuticals
- Lannett
- Lilly Pharmaceuticals
- Liptis Pharmaceuticals
- Lonza Group
- Lupin
- Mallinckrodt Pharmaceuticals
- Medichem
- Megafine Pharma Ltd
- Merck Millipore
- Molcan
- Morepen
- Mylan N.V
- Nacto Pharma
- Nanomedex Pharmaceuticals
- Novartis Ag
- Novasep
- Novo Nordisk
- Oncobiologics
- Orchid Chemicals & Pharmaceuticals Ltd
- Perrigo
- Pfizer
- Pierre Fabre
- Princeton Biomolecular Research, Inc
- Python Biotech Llc
- Rablon Healthcare Pvt Ltd
- Reva Pharma Pvt Ltd
- Rpg Life Sciences
- Saamya Biotech
- Sandoz International Gmbh
- Saneca Pharmaceuticals
- Sanofi
- Salix Pharmaceuticals
- Scinopharm
- Shasun
- Shreeji Pharma International
- Sigma-Aldrich
- Sterling Biotech Ltd
- Sun Pharmaceutical Industries Ltd
- Surfachem
- Suven Life Science Ltd
- Symbiotec
- Takeda
- Taro Pharmaceuticals
- Teva Pharmaceuticals
- Trifecta Pharmaceuticals
- Welt Care Lifesciences Pvt Ltd
- Wockhardt
- Xellia Pharmaceuticals
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll